About
Technology
Issues
FAQ
Links
Official Page
Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.